EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stem cell‐based interventions for epilepsy: Current progress and future promise

Dinesh Kumar iD, Mehboob's Ashraf, Vrinda Gupta iD, Rajni Tanwar, Thamir M Alshammari, Md Faiyazuddin

Epileptic Disorders · 2026-02 · 28 (1) · 17-32

DOI: 10.1002/epd2.70120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epileptic Disorders, online erschienen am 07.11.2025. Verfasst von Dinesh Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: GNA School of Pharmacy, GNA University, Phagwara, Punjab, India. Hauptthemen laut MEDLINE: Epilepsy, Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy affects millions globally, with a significant proportion of patients remaining refractory to conventional pharmacological and surgical treatments. Stem cell therapy represents a promising regenerative treatment. It can repair damaged neural networks, restore inhibitory balance, and modulate the inflammatory microenvironment characteristic of epileptic brains. Preclinical studies using diverse models, such as pilocarpine, kainic acid, and kindling have demonstrated seizure reduction, cognitive improvements, and histological repair following stem cell transplantation. Various cell types associated with stem cells, such as embryonic growth stem cells, neural growth stem cells, induced pluripotent stem cells, and mesenchymal stem cells, have been explored, each offering unique therapeutic advantages and challenges. Early clinical trials have demonstrated preliminary safety and feasibility, with encouraging trends toward seizure control and improvement in quality of life. Innovative strategies, including gene editing, preconditioning, scaffold integration, and exosome‐based therapies, are being actively developed to overcome existing translational hurdles. Personalized regenerative approaches, regulatory harmonization, and sustainable economic models are crucial for advancing stem cell therapies from experimental settings to mainstream clinical applications. With continued multidisciplinary collaboration and scientific innovation, stem cell treatment holds the caliber for redefining the assessment of the landscape of refractory epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyStem Cell TransplantationHumansAnimals

Stichwörter der Autor:innen

epilepsygene editinginduced pluripotent stem cellsmesenchymal stem cellsneural regenerationneural stem cellspreclinical studiesstem cell therapy

Autor:innen und Institutionen

  • GNA School of Pharmacy, GNA University, Phagwara, Punjab, India.
  • Research Scholar, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
  • Assistant Professor, Indo Global College, New Chandigarh, Punjab, India.
  • Research Scholar, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India.
  • Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
  • Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.

ORCID-Profile: Dinesh Kumar, Vrinda Gupta

Zitieren

APA

Kumar, D., Ashraf, M., Gupta, V., Tanwar, R., Alshammari, T. M., & Faiyazuddin, M. (2026). Stem cell‐based interventions for epilepsy: Current progress and future promise. Epileptic Disorders, 28(1), 17-32. https://doi.org/10.1002/epd2.70120

Vancouver

Kumar D, Ashraf M, Gupta V, Tanwar R, Alshammari TM, Faiyazuddin M. Stem cell‐based interventions for epilepsy: Current progress and future promise. Epileptic Disorders. 2026;28(1):17-32. doi:10.1002/epd2.70120

BibTeX
@article{Kumar2026,
  author = {Kumar, Dinesh and Ashraf, Mehboob's and Gupta, Vrinda and Tanwar, Rajni and Alshammari, Thamir M and Faiyazuddin, Md},
  title = {Stem cell‐based interventions for epilepsy: Current progress and future promise},
  journal = {Epileptic Disorders},
  year = {2026},
  volume = {28},
  number = {1},
  pages = {17--32},
  doi = {10.1002/epd2.70120}
}
Kostenlos starten →